Utah Slaps GSK With Medicaid Fraud Suit Over Avandia

Law360, New York (November 12, 2010, 5:27 PM EST) -- Utah has sued GlaxoSmithKline PLC, accusing the pharmaceutical giant of defrauding the state's Medicare program of the $7.8 million it spent on the recently restricted diabetes drug Avandia.

GSK engaged in a long-running pattern of deceptive conduct in marketing the diabetes drug, claiming that Avandia reduced the risk of heart disease despite the results of several studies showing a link between Avandia use and an increased risk of heart attacks, according to the complaint filed Tuesday in Salt Lake City's county court by Utah's attorney general....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.